A derivative of male hormone Dihydrotestosterone (DHT)  boosts longevity: Dihydrotestosterone (DHT) slows down cardiac aging, and increases lifespan, via up-regulation of BubR1 and others genes, 17/April/2019, 11.28 pm

Embryo-derived peptide functions as a stroke medicine: Synthetic PreImplantation factor (sPIF) attenuates hippocampal neurons injury, augments regenerative neurogenesis after Ischemic Stroke, and ameliorates stroke damage and neurological deficits, via up-regulation of its target genes BDNF and NAMPT, 16/April/2019, 11.29 pm
April 16, 2019
The anti-diabetic drug Canagliflozin protects against Myocardial Infarction and its associated complications: Canagliflozin (brand name: Invokana and Sulisent), a sodium -glucose co-transporter-2 inhibitor used in the treatment of TIIDM, inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction, via up-regulation of PNUTS, 18/April/2019, 6.50am
April 18, 2019
Show all

 What they say: Introduction: 

A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston, USA; and Department of Pharmacology, School of Medicine, The University of New South Wales, Australia shows that Sirtuin-2 induces the checkpoint kinase BubR1 to increase lifespan. This study was published, in the 1 July  2014 issue of the journal  “EMBO”, by Prof Sinclair, North BJ, and others.


What we say: 

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: A derivative of male hormone Dihydrotestosterone (DHT)  boosts longevity: Dihydrotestosterone (DHT) slows down cardiac aging, and increases lifespan, via up-regulation of BubR1 and others genes

 


From research findings to Therapeutic Opportunity: 

This study suggests, for the first time, that Dihydrotestosterone (DHT)by increasing the expression of its target gene, may: (a) increase the expression of BuBR1 (BUB1 Mitotic Checkpoint Serine/Threonine Kinase); (b) decrease the expression of p70 S6 Kinase; and (c) regulate the expression of a number of longevity-promoting molecules (fig. 1).

Figure 1. Dihydrotestosterone (DHT) functions as a longevity promoter.  Dihydrotestosterone (DHT)  may extend  mammalian lifespan, via up-regulation of BuBR1; and down-regulation of p70 S6 Kinase

Figure 2. Dihydrotestosterone (DHT) functions as a longevity-promoter through induction of BuBR1.

Thereby, it may: (1) increase insulin sensitivity; (2) attenuate cognitive impairment; (3) delay diseases of aging; (4) slow down cardiac aging; (5) promote resistance to bone, immune and motor dysfunction; (6) promote tissue rejuvenation; and (7) prolong median lifespan. Thus, Dihydrotestosterone (DHT) or its analogs, either alone or in combination with other drugs, may be used to extend the lifespan of an individual (fig.2).

[easy_payment currency=”USD”]


Details on the research findings: 

Idea Proposed/Formulated (with experimental evidence) by Dr L Boominathan Ph.D.

Amount: $750#

Undisclosed mechanistic information: How Dihydrotestosterone (DHT)  increases the expression of BubR1 and extends mammalian life-span

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

# Research cooperation


References

Web: http://genomediscovery.org or http://newbioideas.com

CitationBoominathan, L.,  A derivative of male hormone Dihydrotestosterone (DHT)  boosts longevity: Dihydrotestosterone (DHT) slows down cardiac aging, and increases lifespan, via up-regulation of BubR1 and others genes, 17/April/2019, 11.28 pm,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at admin@genomediscovery.org

 

 

Comments are closed.